Stacey Ma, PhD, serves as Executive Vice President of Pharmaceutical Development and Manufacturing, with responsibility for all the company’s investigational compounds and marketed products. Stacey joined Gilead in 2022 after more than two …

Jun 2, 2022 · Ma will succeed Dr. Yang, who is retiring from Gilead after nearly three decades. Dr. Ma brings to her new role more than 25 years of experience in process, pharmaceutical and analytical development, quality, technical product and supply chain management, as well as global manufacturing operations.

Stacey Ma, MD, specializes in Allergy and Immunology. Dr. Ma utilizes a shared decision-making approach to provide quality, evidence-based care for patients with a wide range of allergic and immunologic conditions. Dr. Ma is board-certified in Internal Medicine.

Jun 2, 2022 · Ma will succeed Dr. Yang, who is retiring from Gilead after nearly three decades. Dr. Ma brings to her new role more than 25 years of experience in process, pharmaceutical and analytical...

Jun 2, 2022 · Stacey Ma, who was previously the head of technical operations at Sana Biotechnology based in California, will be Gilead’s new executive vice president for pharmaceutical development and...

Aug 7, 2023 · When Stacey Ma was a little girl, her dream was to work with patients as a doctor. “As it turns out, I became an engineer who makes medicine to help patients,” says Stacey, who joined Gilead last summer to lead the Pharmaceutical Development and Manufacturing (PDM) team as Executive Vice President.

Mar 21, 2019 · SEATTLE — Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines for patients, announced today that Stacey Ma, Ph.D. joined the company as Executive Vice President, Technical Operations, where she will oversee process and analytical development, supply chain, quality, and global manufacturing operations.

View the profiles of people named Stacey Ma. Join Facebook to connect with Stacey Ma and others you may know. Facebook gives people the power to share...

Jun 2, 2022 · Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Stacey Ma, PhD will join the company as Executive Vice President, Pharmaceutical Development and Manufacturing, and will become a member of the company’s senior leadership team, reporting to Chairman and Chief Executive Officer Daniel O’Day.